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Abstract The insecticidal efficacy towards Helicoverpa armi-
gera lepidopteran larvae of recombinant Autographa californica
M nucleopolyhedroviruses, expressing depressant and excitatory
scorpion anti-insect selective toxins, was investigated. The ET50
(effective paralysis time 50%) values obtained with the
recombinant viruses expressing the depressant toxin, LqhIT2,
and the excitatory toxin, LqhIT1, were 59 h and 66 h,
respectively, whereas the ET50 value of the wild-type virus was
longer, 87 h post infection. The insecticidal effects obtained when
using two distinct temporally regulated viral promoters revealed
advantage for the very late p10 promoter over the p35 early
promoter. The higher insecticidity of the virus expressing the
depressant toxin compared to the excitatory toxin suggests that
pharmacokinetic factors and/or promoter efficiency may play a
role during infection of insect pest larvae by recombinant
baculoviruses.
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1. Introduction
Baculoviruses are pathogens of invertebrates in general and
of insects in particular. Among them nucleopolyhedroviruses
(Baculoviridae: subgroup A) infective to Lepidoptera are used
as protein expression vectors (reviewed in [1]) and for insect
pest control [2,3]. In order to further minimize the damage to
crops and reduce the overuse of non-speci¢c chemical insecti-
cides further improvement has been sought. The insecticidal
e⁄cacy of baculoviruses (time required to kill the insect) has
been enhanced by 30^40%, when their pathogenicity was com-
bined with expression of anti-insect toxins [4^7]. The scorpion
excitatory toxin AaIT binds exclusively to sodium channels of
insect nervous tissues [8] with high a⁄nity (Kd = 1^3 nM) and
low capacity (1.2^2.0 pmol/mg protein). AaIT has been con-
sidered the most potent anti-insect speci¢c scorpion neurotox-
in due to its immediate contraction e¡ect on £y larvae upon
injection [9]. Hence, this toxin has become a primary target
for engineering baculoviruses [4,6]. Another type of scorpion
anti-insect speci¢c toxins, that kill £y larvae at comparable
LD50 values to those of excitatory toxins, is the depressant
toxin LqhIT2 [10]. Upon injection of blow£y larvae, these
toxins induce a short, transient phase of contraction followed
by a prolonged £accid paralysis [11,12]. Its mechanism of
action involves depolarization of the axonal membrane,
blockage of the evoked action potential, and changes in the
amplitude and the kinetics of the sodium current [13]. Their
£accid properties are attributed to the opening of sodium
channels unabling them to inactivate [13]. LqhIT2 was shown
to have two non-interacting binding sites on locust neuronal
membranes: one of high a⁄nity (Kd = 1 nM) and low capacity
(Bmax = 0.1 pmol/mg) and another of low a⁄nity (Kd =
185 nM) and high capacity (Bmax = 10 pmol/mg). The high
a⁄nity site is the target for binding competition of the excit-
atory anti-insect toxin, AaIT [14,15]. The need for recombi-
nant baculoviruses with improved speed of kill of insect pest
larvae motivated us to compare the insecticidal e⁄cacy of
baculovirus expressing depressant vs. excitatory neurotoxins.
Since the activity of viral promoters is temporally regulated,
we also compared the e⁄cacy of two recombinant baculovi-
ruses expressing the excitatory toxin under the control of the
early p35 and the very late p10 promoters. Our results indi-
cate that the insecticidal e⁄cacy of Autographa californica
M nucleopolyhedrovirus (AcMNPV) producing the depres-
sant toxin was signi¢cantly improved compared to the e⁄cacy
achieved with the expressed excitatory toxin.
2. Materials and methods
2.1. Cell lines and viruses
Spodoptera frugiperda SF9 and BTI-TN-5B1-4 cells were main-
tained and propagated in TNM-FH medium supplemented with
10% heat inactivated fetal bovine serum [7,16]. Infection of the cells
with wild-type AcMNPV strain E2 [17], and plaque titration of virus
stocks were as described previously [18].
2.2. Construction of recombinant viruses
The LqhIT2 [19] and LqhIT1 [20] cDNAs, coding for the depres-
sant and excitatory anti-insect-selective toxins, respectively, were en-
gineered via PCR at their 5P- and 3P-termini using oligonucleotide
primers. Primer-1, 5P-CCGGATCCAAGATGAAAC(C/T)TATT(G/
A)CTTTA-3P, for the N-terminal leader sequence, and primer-2, 5P-
CCGGATCC(C/T)TAACCGCATGT(A/G)TT(G/T)GTT-3P, for the
complementary strand at the region encoding the C-terminus, were
used to reconstruct LqhIT2-cDNA. Primer-3, 5P-TCTAGAACC-
TAGTGGATCC-3P, for leader sequence, and primer-4, 5P-CC-
GGATCCCTAATTAATTATTGTGAAATC-3P, for the complemen-
tary strand at the region encoding the C-terminus, were used to
engineer LqhIT1-cDNA. The underlined sequences designate BamHI
restriction sites that were used for cloning into the transfer vector
pAcUW51.P2 (Fig. 1). Thus, two plasmids were obtained, pAcLIT2.-
pol and pAcLIT1.p10, bearing LqhIT2 and LqhIT1 cDNAs, under
the control of the polyhedrin and p10 promoters, respectively. To
construct the plasmid pAcLIT1.p35 (Fig. 1), the p35 promoter se-
quences were PCR-ampli¢ed from plasmid pBB/BSst [21] using pri-
mer-5, 5P-CCGGATCCTCGGTGGCGTACACGTAGTA-3P, and
primer-6, 5P-TACCGGAAAAATTAGATCTATTTTGCTATG-3P.
The reconstructed DNA fragment was cloned back-to-back upstream
of the polyhedrin gene in plasmid pI1 [7]. The engineered LqhIT1-
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cDNA was cloned downstream of the p35 promoter in the newly
created BglII site, underlined in primer 6 (Fig. 1). Organization and
DNA sequences of the resulting plasmids were con¢rmed by DNA
sequencing [22]. Recombinant viruses were isolated by co-transfecting
SF9 cells with the transfer vectors and with linearized polyhedra-neg-
ative AcMNPV DNA using the calcium-phosphate method [23]. Poly-
hedra-positive recombinant viruses, AcLIT2.pol, AcLIT1.p10 and
AcLIT1.p35, were isolated by three rounds of plaque puri¢cation
and veri¢ed by restriction enzyme and PCR analyses of the viral
DNA.
2.3. Expression, N-terminus sequencing, and biological assays
Production of the toxins in recombinant virus-infected BTI-TN-
5B1-4 cells was detected immunochemically [7] using rabbit anti-
LqhIT2 and anti-LqhIT1 sera.
Metabolic labeling was performed by adding 40 WCi of a
[35S]methionine/cysteine mixture (speci¢c activity 1200 Ci/mmol,
New England Nuclear, UK) to methionine/cysteine-de¢cient Grace
medium for an incubation period of 1 h. Then, the medium was
replaced, and after 1 h (chase) cell extracts were analyzed by SDS-
PAGE and autoradiography [24]. For protein sequencing, the toxin
bands were run on a high resolution polyacrylamide gel (18%), trans-
ferred onto a PVDF membrane (Millipore Co.), and treated as de-
scribed previously [7]. Wild type or recombinant baculovirus infec-
tions of 1st instar Helicoverpa armigera larvae were performed by
injection of budded viruses, or by the oral route using polyhedral
inclusion bodies as described previously [7].
3. Results
3.1. Expression of LqhIT1 and LqhIT2 by recombinant
AcMNPVs
BTI-TN-5BI-4 Trichoplusia ni insect cells were infected with
the recombinant budded viruses AcLIT2.pol, AcLIT1.p10,
and AcLIT1.p35. Expression of LqhIT1, controlled by the
very late promoter p10, and that of LqhIT2, controlled by
the very late promoter polyhedrin, is shown in Fig. 2.
The de novo synthesis of the depressant toxin LqhIT2 was
followed by metabolic labeling using a mixture of
[35S]methionine and cysteine (see Section 2), accompanied by
immunodetection of the labeled product (Fig. 3A and 3B,
respectively). LqhIT2 synthesis was ¢rst detected at 24 h
post infection (Fig. 3A, lane 2 and Fig. 3B, lane 2). An in-
creased rate of synthesis of LqhIT2 was observed between 36
to 48 h post infection (Fig. 3A, lanes 3 and 4 respectively).
Also, it can be seen that LqhIT2 accumulated in the infected
cells at 48 h post infection (Fig. 3B, lane 4). The LqhIT2
product appeared as a double band on high resolution poly-
acrylamide gels (Fig. 2C). Amino acid sequence analysis de-
termined the slower running band to be the precursor of
LqhIT2, i.e. with its intact leader peptide, while the faster
running band was the mature toxin (Fig. 3C). It is possible
that at late stages of baculovirus infection the secretory path-
way of the host is negatively a¡ected [25], or perhaps satu-
rated. This may explain the two forms appearing in the cell
extracts.
The activity of the toxins produced by the recombinant
baculoviruses was also assessed by injection of 3rd instar S.
littoralis larvae with the AcLIT2.pol, AcLIT1.p10, and
AcLIT1.p35 budded viruses (BVs). Three to four days post
injection, characteristic paralysis induced by both toxins was
observed regardless of the recombinant virus injected. West-
ern blot analysis of the infected larvae hemolymph revealed a
detectable amount of toxin expressed under the control of the
very late promoters, whereas LqhIT1 could not be detected
when the expression was driven by the early p35 promoter
(under our experimental conditions detectable LqhIT1 quan-
tities exceeded 100^150 ng of toxin on Western blots).
3.2. Depressant vs. excitatory paralysis induced by baculovirus
infection
The ‘time to paralysis’ of 1st instar H. armigera fed with the
recombinant baculoviruses (measured by immobility of the
larvae) was determined. AcLIT2.pol, expressing the depres-
sant toxin, provided a signi¢cantly lower ET50 value, 59 h,
than that calculated for AcLIT1.p10 expressing the excitatory
toxin, 66 h (Fig. 4A and Table 1). The ET50 values of
AcLIT1.p35 infections were 73 h (Fig. 4 and Table 1).
Thus, the p10-driven LqhIT1 expression induced faster paral-
ysis than the p35-driven LqhIT1 expression (Fig. 4B and
Table 1).
ED50 values obtained were of 0.9U103, 1.1U103, 2.2U103,
for the recombinant AcLIT2.pol, AcLIT1.p10, and
AcLIT1.p35, respectively, vs. 1.4U103 for the wild type
AcMNPV (Table 1).
Evidently, the baculovirus expressing the depressant toxin
showed improved insecticidal e⁄cacy (faster paralysis) com-
pared to the virus expressing the excitatory toxin.
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Fig. 1. Construction of transfer vectors utilized to isolate the re-
combinant baculoviruses. The toxin cDNAs (black arrows) were
cloned juxtaposed to the p35, p10 and pol (polyhedrin) promoters
yielding the vectors pAcLIT1.p35, pAcLIT1.p10 and pAcLIT2.pol,
respectively (see Section 2).
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4. Discussion
Biotechnology has already proven useful in generating nov-
el biopesticides aiming at reducing current overuse of hazard-
ous insecticidal chemicals [26]. The restricted host range of
baculoviruses and their ability to penetrate upon feeding
into the internal tissues of lepidopterous pests, make them
ideal vectors for mobilizing selective toxins into target insects
with minor predicted e¡ects on the environment. This ap-
proach has been recently demonstrated with AcMNPVs bear-
ing various arachnid toxin genes [4^7]. Among scorpion tox-
ins, the excitatory toxin, AaIT, has been the focus of these
experiments, since it is considered as the most potent anti-
insect speci¢c scorpion neurotoxin [9]. Despite its high toxicity
upon injection to £y larvae, locusts, some beetles and isopods
[27], this toxin, as well as other scorpion toxins, shows weak
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Fig. 2. AcMNPV-mediated expression of LqhIT2 and LqhIT1 anti-insect toxins in insect cells. BTI-TN-5B1-4 cells were infected with
AcLIT1.p10 (A, lane 3) and AcLIT2.pol (B, lanes 1^3, indicating expression from three di¡erent isolates and C, lane 2) recombinant viruses or
with wild type AcMNPV (A and B, lanes 2 and 4, respectively). Cell extracts at 48 h post infection were subjected to SDS-PAGE and immuno-
blot analysis using anti-LqhIT1 (A) and anti-LqhIT2 (B and C) antisera. LqhIT1 and LqhIT2 markers are indicated (A, lane 1, and B and C,
lanes 5 and 1, respectively). C: High resolution SDS-polyacrylamide gel. Arrows a and b, band of LqhIT2 toxin.
Fig. 3. Time-course expression of LqhIT2 in insect cells. A: 35S-amino acid metabolic labeling of AcLIT2.pol and AcMNPV-infected cells. B:
Immunoblot analysis. C: N-terminal amino acid sequence of the natural (n) and recombinant (r) LqhIT2 toxins. Time (h) post infection is indi-
cated above each lane. M, size marker, values (kDa) indicated on the right hand side. rLqhIT2s 7 kDa and rLqhIT26 7 kDa in C, correspond
to the upper and lower bands seen in Fig. 2B and C (arrows a and b), resolved and identi¢ed as described in Section 2. Underlining in
nLqhIT2 corresponds to the leader peptide.
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and delayed e¡ects when injected to Spodoptera or Helicover-
pa larvae. This phenomenon suggested either possible barriers
unabling the toxins to reach their receptor sites, or enhanced
metabolic degradation in these noctuid larvae. Strikingly,
these toxins are very e¡ective in the context of baculovirus
mediated expression [4^7]. The tracheal system of the host was
shown as a major conduit of baculovirus infections [28]. Thus,
it is conceivable that expression of the scorpion toxins adja-
cent to their target sites in motor neural tissues overcomes
pharmacokinetic barriers and may be responsible for their
enhanced e¡ects when compared to injection experiments of
puri¢ed toxins. Support for this suggestion may be provided
by the results obtained with LqhIT1 expression. We were able
to detect a clear paralytic e¡ect using the p35 promoter, com-
parable to the p10-mediated expression of this toxin, although
we could not detect the toxin immunochemically in the hemo-
lymph. It seems that a small amount of toxin is required for
such an e¡ect when its expression is directed by a baculovirus
vector. It was also reported by McCutchen et al. [6] that very
low amounts, 1^2 ng/Wl, of baculovirus-expressed AaIT were
found in the hemolymph of paralyzed Heliothis virescens lar-
vae. These results show great improvement over those ob-
tained by injection of pure AaIT [29] and recombinant
LqhIT2 (unpublished).
Although the excitatory toxin generates an immediate pa-
ralytic e¡ect in £y larvae in contrast to the delayed e¡ect of
the depressant toxin, the baculovirus-driven expression of
these toxins in lepidopterous larvae, reveals an opposite phe-
nomenon (Fig. 4 and Table 1). This e¡ect could occur due to:
1. Pharmacokinetic di¡erences between excitatory and de-
pressant toxins. If depressant toxins expressed by
AcMNPV in noctuid larvae are more stable than exci-
tatory toxins, their bioactivity may be better pro-
nounced and explain the improved insecticidal e⁄cacy
of AcLIT2.pol vs. AcLIT1.p10.
2. Di¡erences in promoter e⁄ciency. p10 and polyhedrin
promoters are both very late strong promoters, but may
not be equally active.
Tomalski and Miller suggested that the concentration of the
toxin and its early appearance during infection, should be
considered to further improve the e⁄cacy of baculoviruses
[5]. The results obtained when utilizing the p10 and p35 pro-
moters (Table 1 and Fig. 4) support this hypothesis.
Finally, our results suggest, that the insecticidal e⁄cacy of a
given scorpion toxin should be evaluated in vivo, e.g. by ex-
pression of baculoviruses, and cannot solely rely on its para-
lytic e¡ects observed upon injection of test animals such as
blow£y larvae.
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LqhIT1 under the control of early and very late baculovirus pro-
moters p35 and p10, respectively. AcMNPV, wild type virus. Dose
per treatment was 4U103 PIBs/mm2.
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